Moderator:
TBC
08:35 - 09:15Immunity, inflammation and cancer: basics
Dr. Juan F. García
MD Anderson Cancer Center Madrid, Spain
09:15 - 09:55Immune Checkpoint Therapies: A Review for Pathologists
Dr. Ana Aparicio
MD Anderson Cancer Center, Houston, USA
09:55 - 10:35Drugs and biomarkers in solid tumors
PDL1, regulation and multiplex immunprofiling
Dr. José Luis Solórzano
MD Anderson Cancer Center Madrid, Spain
10:35 - 11:15Cutaneous complications of immunotherapy
Dr. Jonathan Curry
MD Anderson Cancer Center, Houston, USA
11:15 - 11:30Discussion
Moderator:
Dr. Pilar López-Criado
MD Anderson Cancer Center Madrid, Spain
11:50 - 12:30Predictive biomarkers for lung cancer immunotherapy
Dr. Ignacio Wistuba
MD Anderson Cancer Center, Houston, USA
12:30 - 13:10TBC
Dr. Montserrat Sánchez-Céspedes
Josep Carreras Leukemia Research Institute, Barcelona, Spain
13:10 - 13:50Rare H&N aggressive neoplasms: salivary gland, NUT
Dr. Michelle Williams
MD Anderson Cancer Center, Houston, USA
13:50 - 14:05Discussion
Moderator:
Dr. Juan F. García
MD Anderson Cancer Center Madrid, Spain
15:35 - 16:15Immunotherapy in B-cell lymphomas and leukemias
Dr. Joseph Khoury
MD Anderson Cancer Center, Houston, USA
16:15 - 16:55CD30 as a diagnostic marker and target of therapy
Dr. Roland Schwarting
Cooper University Health Care, New Jersey, USA
16:55 - 17:35CAR-T technology: present and future
Dr. Manel Juan
Hospital Clinic-IDIBAPS, Barcelona, Spain
17:35 - 17:50Discussion
Moderator:
TBC
Special seminar: four to six cases focused on immunotherapy/biomarkers, illustrating the role of molecular pathology in clinical decision making processes